Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 2Unknown 1Terminated 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1Dermatologic 1

Conditions

Sezary Syndrome 1Recurrence 1Mycosis Fungoides 1Lymphoma, T-Cell, Cutaneous 1Lymphoma 1Breast Neoplasms 1

Interventions

Psychiatric Rehabilitation 2romidepsin 1motesanib diphosphate 1fludarabine phosphate 1carbendazim 1Ultraviolet Therapy 1Therapeutics 1Ritonavir 1Radiotherapy 1Polymerase Chain Reaction 1Phototherapy 1Pharmacogenomic Testing 1Peripheral Blood Stem Cell Transplantation 1Mycophenolic Acid 1Methylprednisolone 1Methoxsalen 1Melphalan 1Levofloxacin 1Lenalidomide 1Ketamine 1Interleukin-12 Subunit p35 1Indinavir 1Gemcitabine 1Fluconazole 1Flow Cytometry 1Doxycycline 1Cyclosporine 1Cord Blood Stem Cell Transplantation 1Ciprofloxacin 1Cefepime 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Mycosis Fungoides × Interleukin-12 Subunit p35 × Clear all
NCT02542124 2018-11-16

NM-IL-12 in Cutaneous T-Cell Lymphoma (CTCL) Undergoing Total Skin Electron Beam Therapy (TSEBT)

Neumedicines Inc.

Phase 2 Unknown
10 enrolled
DermatologicLymphoid

Mycosis Fungoides, Sezary Syndrome, Lymphoma, T-Cell, Cutaneous

Data powered by HemOnc (CC BY 4.0) Colophon âš¡